Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
The FDA has made strides to improve its medical device review pathways, but what’s the real-world experience for medtech companies? Reuters recently reported that a growing number of U.S. cardiologists are expressing frustration with the lack of availability of newer cardiac devices in the United States as compared to Europe. Their beef: U.S. patients have to wait longer for access to beneficial next generation therapies.
Hey, check out all the engineering jobs. Post your resume today!
